Leigh MacMillan Archive — Page 49 of 85

Lymphocytes attacking cancer cell
August 31, 2017

Pancreatic cancer development

Elevated levels of the factor G-CSF appear to promote the development of aggressive pancreatic cancer, suggesting a new therapeutic approach for this devastating disease.

By Leigh MacMillan
Three women pose together indoors; the two women on either side wear white medical coats, and colorful gift items are visible in the foreground.
August 26, 2017

All over the Medical Center, and all over the world

When Debby Booth started college in the early 1970s, she didn’t want to be a nurse. That was something her older sister did.

By Leigh MacMillan
Head-and-shoulders portrait of a smiling man wearing a light blue shirt and red patterned tie.
August 24, 2017

Grants bolster research on rare neurological disorder AHC

Kevin Ess, M.D., Ph.D., Gerald M. Fenichel Professor of Neurology, has received two grants from the Alternating Hemiplegia of Childhood Foundation (AHCF).

By Leigh MacMillan
Two salmon steaks, halved avocados, a bowl of oil, flaxseeds, and assorted nuts arranged on a dark surface.
August 21, 2017

Fatty acids and adenoma risk

Vanderbilt researchers have found that red blood cell membrane fatty acid content is associated with risk of having colorectal adenomas, with omega-6 fatty acids increasing and omega-3 fatty acids decreasing risk.

By Leigh MacMillan
colored representation of cells and glia
August 17, 2017

Discovery sheds light on protein key to nerve cells’ myelin sheath

Genetic mutations in PMP22 (peripheral myelin protein 22) cause a variety of peripheral neuropathies, underscoring the importance of the protein to a healthy peripheral nervous system. But the precise function of PMP22, a major component of the myelin sheath that surrounds and insulates peripheral nerve cell axons, has been unclear.

By Leigh MacMillan
Stylized blue illustration of human lungs with branching airways.
August 17, 2017

Block estrogen to treat lung disease

Based on findings from Vanderbilt investigators and others, clinical trials of estrogen inhibition for pulmonary arterial hypertension have recently been approved and funded by the National Institutes of Health.

By Leigh MacMillan